Gastric anti-ulcerative and anti-inflammatory activity of metyrosine in rats
Tóm tắt
In this study, the anti-inflammatory and anti-ulcerative effects of metyrosine, a selective tyrosine hydroxylase enzyme inhibitor, were investigated in rats. For ulcer experiments, indomethacin-induced gastric ulcer tests and ethanol-induced gastric ulcer tests were used. For these experiments, rats were fasted for 24 h. Different doses of metyrosine and 25 mg/kg doses of ranitidine were administered to rats, followed by indomethacin at 25 mg/kg for the indomethacin-induced ulcer test, or 50% ethanol for the ethanol-induced test. Results have shown that at all of the doses used (50, 100 and 200 mg/kg), metyrosine had significant anti-ulcerative effects in both indomethacin and ethanol-induced ulcer tests. Metyrosine doses of 100 and 200 mg/kg (especially the 200 mg/kg dose) also inhibited carrageenan-induced paw inflammation even more effectively than indomethacin. In addition, to characterize the anti-inflammatory mechanism of metyrosine we investigated its effects on cyclooxygenase (COX) activity in inflammatory tissue (rat paw). The results showed that all doses of metyrosine significantly inhibited high COX-2 activity. The degree of COX-2 inhibition correlated with the increase in anti-inflammatory activity. In conclusion, we found that metyrosine has more anti-inflammatory effects than indomethacin and that these effects can be attributed to the selective inhibition of COX-2 enzymes by metyrosine. We also found that adrenalin levels are reduced upon metyrosine treatment, which may be the cause of the observed gastro-protective effects of this compound.
Tài liệu tham khảo
Bradford MM: Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem, 1976, 72, 248–254.
Brater DC: Renal effects of cyclooxygyenase-2-selective inhibitors. J Pain Symptom Manage, 2002, 23, S15–S20.
Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T: Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol, 2005, 56, Suppl 5, 33–55.
Burke A, Smyth E, FitzGerald GA: Analgesic-antipyretic agents: pharmacotherapy of gout. In: Goodman & Gil-man’s the Pharmacological Basis of Therapeutics. Ed. Brunton LL, The McGraw-Hill Companies, New York, 2006, 695–696.
Buttgereit F, Burmester GR, Simon LS: Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors. Am J Med, 2001, 110, Suppl 1, 13–19.
Cadirci E, Suleyman H, Aksoy H, Halici Z, Ozgen U, Koc A, Ozturk N: Effects of Onosma armeniacum root extract on ethanol-induced oxidative stress in stomach tissue of rats. Chem Biol Interact, 2007, 170, 40–48.
Collier DS, Pain JA: Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut, 1985, 26, 359–363.
Dunne MW: Inflammation and repair. In: Pathophysiology. Ed. Porth CM, Lipincott, Philadelphia, 1990, 165–176.
Fulop K, Zadori Z, Ronai AZ, Gyires K: Characterisation of α2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence. Eur J Pharmacol, 2005, 528, 150–157.
Gamache DA, Povlishock JT, Ellis EF: Carrageenan-induced brain inflammation - characterization of the model. J Neurosurg, 1986, 65, 679–685.
Guidobono F, Pagani F, Ticozzi C, Sibilia V, Pecile A, Netti C: Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br J Pharmacol, 1997, 120, 581–586.
Gyires K, Mullner K, Furst S, Ronai AZ: Alpha-2 adren-ergic and opioid receptor-mediated gastroprotection. J Physiol (Paris), 2000, 94, 117–121.
Higgins AJ: The biology, pathophysiology and control of eicosanoids in inflammation. J Vet Pharmacol Ther, 1985, 8, 1–18.
Hoffman BB: Therapy of hypertension. In: Goodman & Gilman’s the Pharmacological Basis of Therapeutics. Ed. Brunton LL. The McGraw-Hill Companies, New York, 2006, 845–897.
Katori M, Majima M: Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res, 2000 49, 367–392.
Laudanno OM, Cesolari JA, Esnarriaga J, Rista L, Piombo G, Maglione C, Aramberry L et al.: Gastrointestinal damage induced by celecoxib and rofecoxib in rats. Dig Dis Sci, 2001 46, 779–784.
Laudanno OM, Cesolari JA, Esnarriaga J, San Miguel P, Bedini OA: In vivo selectivity of nonsteroidal antiin-flammatory drugs and gastrointestinal ulcers in rats. Dig Dis Sci, 2000, 45, 1359–1365.
Luo GY, He Y, Tu LB: Effects of clonidine on experimental stomach ulcer in rats (in Chinese). Zhongguo Yao Li Xue Bao, 1990, 11, 457–459.
Marzocco S, Di Paola R, Serraino I, Sorrentino R, Meli R, Mattaceraso G, Cuzzocrea S et al.: Effect of methyl-guanidine in carrageenan-induced acute inflammation in the rats. Eur J Pharmacol, 2004, 484, 341–350.
Mitchell JA, Warner TD. Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol, 1999, 128, 1121–1132.
Mukherjee D: Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events. Biochem Pharmacol, 2002, 63, 817–821.
Reams G, Bauer JH: Pharmacologic treatment of hypertension. In: Atlas of diseases of the kidney. Ed. Wilcox CS, Blackwell Science, Philadelphia, 1999, 28–30.
Schmidt KM, Klopfer FD: Ethanol and stomach ulcers: absence of influence in the albino rat. Q J Stud Alcohol, 1968, 29, 558–565.
Steinmeyer J: Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res, 2000 2, 379–385.
Suleyman H, Akcay F, Altinkaynak K: The effect of ni-mesulide on the indomethacin- and ethanol-induced gastric ulcer in rats. Pharmacol Res, 2002, 45, 155–158.
Suleyman H, Cadirci E, Albayrak A, Halici Z: Nimesu-lide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem, 2008, 15, 278–283.
Suleyman H, Cadirci E, Albayrak A, Halici Z, Polat B, Hacimuftuoglu A, Alp HH: The reason of the aggravation of the diseases which are going with inflammation and ineffectiveness of NSAIDs on them in rainy weather. Pharmacol Rep, 2009, 61, 514–519.
Suleyman H, Demircan B, Gocer F, Halici Z, Hacimuftuoglu A: Role of adrenal gland hormones in the mechanism of antiulcer action of nimesulide and ranitidine. Pol J Pharmacol, 2004, 56, 799–804.
Suleyman H, Demirezer LO, Kuruuzum-Uz A: Effects of Rumex patientia root extract on indomethacine and ethanol induced gastric damage in rats. Pharmazie, 2004, 59, 147–149.
Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Bilen H: Indirect role of β2-adrenergic receptors in the mechanism of anti-inflammatory action of NSAIDS. J Physiol Pharmacol, 2008, 59, 661–672.
Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Keles S, Gocer F: Indirect role of α2-adrenoreceptors in anti-ulcer effect mechanism of nimesulide in rats. Naunyn Schmiedebergs Arch Pharmacol, 2007, 375, 189–198.
Wallace JL: Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology, 1997, 112, 1000–1016.